Here is some information from the Harvard Medical School that may give hope to people that suffer from allergies, especially those that are having a hard time finding relief.

 
Researchers at the School of Medicine of the University of California, Los Angeles (UCLA), are working on a new type of subcutaneous immunotherapy, or SCITâ€"commonly called allergy shotsâ€"designed to provide protection against the type of allergies that do not typically respond well to traditional SCIT (such as cat allergies) or that are too dangerous to be treated this way (such as food allergies).

The work is in its earliest stages, but it is generating considerable interest in the scientific community.

The UCLA researchers have designed a protein (made by fusing a cat protein, Fel d 1, and a human immune system
molecule, IgG Fcg1) that simultaneously boosts immune response while shutting down an allergic response to cats.

The method has been tested in mice (who were bred to be allergic to the cat protein) and in cultured blood samples from people. This research is being funded by the NIAID

Excerpt from Harvard Medical School Special Report.

Wishing you the best of health
Mike Krause
AllergyStore.com - Serving Customers Since 1989
800 771-ACHOO